Governance Zoetis Inc.

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse Other stock markets 00:00:03 24/01/2026 +03			5-day change	1st Jan Change
124.05 ^USD	-0.28%		-0.48%	-1.41%

01-22	Escalate, De-Escalate, Repeat
01-22	Piper Sandler Downgrades Zoetis to Neutral From Overweight, Adjusts Price Target to $135 From $190	MT

Executive Committee: Zoetis Inc.

Manager

Positions heldSince

Kristin Peck

54 year

Chief Executive Officer

01/01/2020

Julie Fuller

53 year

Chief Operating Officer	01/08/2024
Human Resources Officer	01/08/2024

Richard Goldstein

Chief Tech/Sci/R&D Officer

21/03/2024

Keith Sarbaugh

48 year

Chief Tech/Sci/R&D Officer

01/03/2023

Wetteny Joseph

54 year

Director of Finance/CFO

01/06/2021

Roxanne Lagano

61 year

General Counsel	16/04/2024
Corporate Secretary	16/04/2024

Steven Frank

Investor Relations Contact

01/03/2015

Kevin Esch

Chief Tech/Sci/R&D Officer

01/01/2026

Composition of the Board of Directors: Zoetis Inc.

Director

CommitteesSince

Michael McCallister

73 year

Audit Committee	01/11/2011
HR Committee	01/02/2013

Frank D'Amelio

68 year

Governance Committee
Nominating Committee
Audit Committee Chair	01/09/2003
Audit Committee	10/01/2023
HR Committee Chair
Finance Committee	05/05/2025

Gregory Norden

68 year

HR Committee
Audit Committee Chair	01/03/2019
Governance Committee	30/07/2020
Nominating Committee	30/07/2020
Compensation Committee	01/03/2019

Antoinette Leatherberry

64 year

Audit Committee	01/02/2022
HR Committee
Compensation Committee	01/02/2022
Governance Committee Chair	01/02/2022
Nominating Committee Chair	01/02/2022

Sanjay Khosla

73 year

HR Committee
Governance Committee	01/09/2021
Nominating Committee	01/09/2021
Compensation Committee Chair	01/09/2021

Paul Bisaro

65 year

HR Committee	01/05/2015
Governance Committee	31/10/2022
Nominating Committee	31/10/2022

Louise Parent

75 year

Audit Committee	01/08/2013
Governance Committee Chair

Kristin Peck

54 year

Governance Committee	01/10/2024
Nominating Committee	01/10/2024

Stephanie Schear-Tilenius

59 year

Audit Committee	01/01/2014
Finance Committee	01/01/2014

Willie Reed

71 year

Governance Committee

04/03/2014

Gavin Hattersley

63 year

Governance Committee

01/04/2024

Vanessa Broadhurst

57 year

Governance Committee

Mark Stetter

Director/Board Member	21/05/2025
Independent Dir/Board Member	21/05/2025

Latest Appointments: Zoetis Inc.

11-04	Zoetis announces retirement of Rob Polzer at the end of 2025 and the appointment of Kevin Esch as president of research & development for world leader in animal health beginning in 2026	RE
11-04	Zoetis Inc. Announces Executive Changes	CI
28/10/25	Zoetis Inc. Appoints Stephanie Tilenius to Its Board of Directors, Effective December 1, 2025	CI
28/10/25	Zoetis appoints Stephanie Tilenius to its board of directors	RE
22/05/25	Zoetis Inc. Announces Board Changes Effective May 21, 2025	CI
22/05/25	Zoetis Inc. Approves the Election of Dr. Mark Stetter to Its Board of Directors, Effective from May 21, 2025	CI
20/03/25	Roche Announces Management Changes	CI

More news

Former Officers and Directors: Zoetis Inc.

Insider

Positions held

SinceUntil

Robert Polzer

Chief Tech/Sci/R&D Officer	01/01/2022	31/12/2025
Corporate Officer/Principal	01/01/2015	01/01/2022

Robert Scully

Director/Board Member	01/06/2013	21/05/2025
Independent Dir/Board Member	01/06/2013	21/05/2025

Ester Banque

Corporate Officer/Principal

10/07/2023

11/11/2024

Wafaa Mamilli

Chief Tech/Sci/R&D Officer

01/01/2020

11/11/2024

Mike McFarland

Chief Tech/Sci/R&D Officer

01/11/2020

01/08/2024

Linda Rhodes

Director/Board Member	04/08/2017	21/05/2024
Independent Dir/Board Member	04/08/2017	21/05/2024

Heidi Chen

General Counsel	01/10/2012	16/04/2024
Corporate Secretary	01/10/2012	16/04/2024

Glenn David

Director of Finance/CFO	18/08/2016	01/06/2021
Corporate Officer/Principal	01/06/2021	05/02/2023

Roman Trawicki

Corporate Officer/Principal

31/07/2022

Catherine Knupp

Chief Tech/Sci/R&D Officer

01/10/2012

31/12/2021

Sherry Pudloski

Public Communications Contact

01/03/2020

01/12/2021

John O'Connor

Investor Relations Contact	-	-
Public Communications Contact	-	-
Corporate Officer/Principal	-	-
Treasurer	-	01/12/2021

William Steere

Director/Board Member	01/01/2013	20/05/2021
Independent Dir/Board Member	07/01/2014	20/05/2021

Katherine Walden

Compliance Officer

01/11/2012

01/05/2021

Pablo Lamberto

Corporate Officer/Principal

01/01/2018

01/01/2021

Andrew Fenton

Chief Tech/Sci/R&D Officer

01/01/2014

01/06/2020

Timothy Bettington

Corporate Officer/Principal

01/01/2020

Juan Alaix

Director/Board Member	01/07/2012	31/12/2019
Chief Executive Officer	01/07/2012	31/12/2019

Clinton Lewis

Corporate Officer/Principal

01/01/2013

31/12/2019

Dong Kim

Comptroller/Controller/Auditor

01/01/2018

01/07/2019

Alejandro Bernal

Corporate Officer/Principal

01/10/2012

28/02/2018

Colleen Cunningham

Comptroller/Controller/Auditor

01/01/2012

01/01/2018

Paul Herendeen

Director of Finance/CFO

02/09/2014

18/08/2016

Stefan Weiskopf

Corporate Officer/Principal

01/10/2012

01/05/2016

Bill Doyle

Director/Board Member	03/02/2015	01/03/2016
Independent Dir/Board Member	03/02/2015	01/03/2016

William Ackman

Director/Board Member

04/02/2015

Joyce Lee

Corporate Officer/Principal

01/10/2012

01/01/2015

Gloria Basse

Corporate Officer/Principal

01/01/1985

01/01/2015

Richard A. Passov

Director of Finance/CFO

01/07/2012

22/04/2014

Ky Nam-Wortman

Corporate Officer/Principal

01/01/2012

01/01/2014

Inez Blankestijn

Human Resources Officer

01/01/2010

01/01/2014

Amy Schulman

Director/Board Member

01/07/2012

24/06/2013

Geno Germano

Director/Board Member

01/07/2012

24/06/2013

Douglas Giordano

Director/Board Member

01/07/2012

24/06/2013

Charles H. Hill

Director/Board Member

01/07/2012

24/06/2013

Jim Bradford

Corporate Officer/Principal

27/03/2012

Scott Webster

Corporate Officer/Principal

27/03/2012

Sandra J. Beaty

Investor Relations Contact	-	-
Corporate Officer/Principal	01/01/2012	-

Ronald Green

Chief Operating Officer

01/01/2008

01/01/2010

Paul Wood

Corporate Officer/Principal

01/01/2004

Gerard G. Gorman

Chief Tech/Sci/R&D Officer	01/01/2001	01/01/2001
Director of Finance/CFO	01/01/2001	01/01/2001

James Fraser MacKenzie

Sales & Marketing

01/01/2001

Nat Ricciardi

Corporate Officer/Principal

01/01/1995

01/01/1999

Rick Ryan

Corporate Officer/Principal

01/01/1996

31/12/1998

Riff Yeager

Corporate Officer/Principal

J. McFarland

Chief Tech/Sci/R&D Officer

Kyung Nam-Wortman

Corporate Officer/Principal

Susanne P. Reilly

Human Resources Officer

Bill Price

Public Communications Contact

George Fennell

Corporate Officer/Principal	-	-
Sales & Marketing	01/04/2003	01/01/2011

Carl-Johan Ehn

Corporate Officer/Principal

George Gunn

President

Ian Read

President

Gerard P. Davis

Director/Board Member

Steve Sornsen

Corporate Officer/Principal

Nigel Hebart

Corporate Officer/Principal

Thomas Darling

General Counsel	09/06/2010	-
Corporate Officer/Principal	-	09/06/2010

Jim Myers

Corporate Officer/Principal

Michael van Blommestein

Corporate Officer/Principal

Roger Schein

Corporate Officer/Principal

Allen Moczygemba

Sales & Marketing

John T. Gray

Corporate Officer/Principal

Olivier Nazeyrollas

Corporate Officer/Principal

Elinore Y. White

Public Communications Contact

David Alan Brake

Corporate Officer/Principal

Colin Giles

Corporate Officer/Principal

Laura Pires

Corporate Officer/Principal

19/04/2011

Michelle Tollefson

Corporate Officer/Principal

19/04/2011

Elizabeth Williams

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	17
Female	8

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	8
Female	5

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.

Employees

13,800

Sector

Pharmaceuticals

Calendar

02-12 - Q4 2025 Earnings Release

More about the company